Pharma companies strengthen their R&D competitivity ; UCB Pharma’s interleukin-17 dual inhibitor ‘Bimzelex’ is approved in KOR ; Domestic biotechs are also developing new drugs... New biosimilars are also expected to emerge
Journal of the Korean Society for Psoriasis,JKSP
Download Citation | Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis A Bayesian Network Meta-analysis | Objective To compare the effic...
Psoriasis ; Author(s): Dr Chelsea Jones, Newcastle, Australia; Dr Monisha Gupta, Dermatologist, Australia (2020); updated by Dr Salim Uddin, Medical Registrar, New Zealand; A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand (2023). Reviewing dermatologist: Dr Ian Coulson · Edited by the DermNet content department
We present a quick overview of current biological therapies in the treatment of psoriasis and prospects for forthcoming advancements in biological treatment. Keywords: biological treatment;...
Abstract Psoriasis is a chronic, systemic, inflammatory skin condition that manifests... medications for remission. The development of biological agents provides dermatologists valuable...
Membership · Meetings & Education · Practice management · Clinical & quality · Publications & apps · Career development · Advocacy · For Public and Patients · Store · Donate
Background and objectives: Biological treatment is an important and effective therapy for psoriasis. During the COVID-19 pandemic, it remains unclear whether this type of therapy affects the course...
Biological agents for psoriasis, Biological response modifiers, Biologic agents, Biologics for psoriasis. Authoritative facts from DermNet New Zealand.
Quo vadis, biological treatment for psoriasis and psoriatic arthritis? Barbara Olszewska, Zygmunt Adamski, Magdalena Czarnecka-Operacz Department of Dermatology, Poznan University of...